Products for Research Use Only

GSK-A1

CAT: 0804-HY-125118-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-125118-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
GSK-A1 is a selective type III phosphatidylinositol 4-kinase PI4KA (PI4KIIIα) inhibitor with a pIC50 of 8.5-9.8. GSK-A1 inhibits PtdIns (4,5) P2 resynthesis with an IC50 of about 3 nM. GSK-A1 potently decreases the levels of PtdIns (4) P with a negligible effect on PtdIns (4,5) P2. GSK-A1 has the potential for anti-hepatitis C virus (HCV) research[1].
CAS Number
1416334-69-4
UNSPSC
12352005
Target
HCV; PI4K
Type
Reference compound
Related Pathways
Anti-infection; PI3K/Akt/mTOR
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/gsk-a1.html
Purity
99.04
Solubility
DMSO : ≥ 2 mg/mL|H2O : < 0.1 mg/mL (ultrasonic)
Smiles
O=S(C1=CC(C2=CC=C3N=C(N)N(C4=CC=C(N5CCOCC5)C=C4)C3=C2)=CN=C1OC)(NC6=CC=CC=C6F)=O
Molecular Formula
C29H27FN6O4S
Molecular Weight
574.63
References & Citations
[1]Naveen Bojjireddy, et al. Pharmacological and genetic targeting of the PI4KA enzyme reveals its important role in maintaining plasma membrane phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate levels. J Biol Chem. 2014 Feb 28;289 (9) :6120-32.|[2]Smulders L, et al. Phosphatidylinositol Monophosphates Regulate the Membrane Localization of HSPA1A, a Stress-Inducible 70-kDa Heat Shock Protein. Biomolecules. 2022 Jun 20;12 (6) :856. |[3]Jiang X, et al. Targeting PI4KA sensitizes refractory leukemia to chemotherapy by modulating the ERK/AMPK/OXPHOS axis. Theranostics. 2022 Oct 3;12 (16) :6972-6988. |[4]Li FL, et al. Hippo pathway regulation by phosphatidylinositol transfer protein and phosphoinositides. Nat Chem Biol. 2022 Oct;18 (10) :1076-1086.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PI4K; PI4KIIIα; PI4KIIIβ